Diebold Nixdorf (DBD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $66.83, +0.39% vs the prior close of $66.57.
- Volume 211.34K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DBD rises 0.4% to $66.83, a 1-month high. Closed at $66.83, +0.39% vs the prior close of $66.57. Day range $65.92β$67.56, opened at $66.70.
DBD daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β DBD rises 0.4% to $66.83, a 1-month high
- Closed at $66.83, +0.39% vs the prior close of $66.57. Day range $65.92β$67.56, opened at $66.70.
- Volume was 211.34K shares, 0.9x its 50-day average of 241.40K.
- Price is +0.8% vs its 50-day average ($66.33) and -11.0% vs its 200-day average ($75.09).
- 52-week range $54.48β$92.08; today's close sits at 33% of that range, 27.4% below the 52-week high.
Oct 15, 2026 β DBD jumps 3.5% to $66.57, a 1-month high
- Closed at $66.57, +3.55% vs the prior close of $64.29. Day range $63.77β$66.88, opened at $64.16.
- Volume was 188.70K shares, 0.8x its 50-day average of 243.45K.
- Price is +0.1% vs its 50-day average ($66.48) and -11.4% vs its 200-day average ($75.10).
- 52-week range $54.48β$92.08; today's close sits at 32% of that range, 27.7% below the 52-week high.
Oct 14, 2026 β DBD dips 1.4% to $64.29
- Closed at $64.29, -1.38% vs the prior close of $65.19. Day range $63.67β$64.80, opened at $64.21.
- Volume was 188.30K shares, 0.8x its 50-day average of 246.99K.
- Price is -3.6% vs its 50-day average ($66.71) and -14.4% vs its 200-day average ($75.11).
- 52-week range $54.48β$92.08; today's close sits at 26% of that range, 30.2% below the 52-week high.
Oct 13, 2026 β DBD jumps 3.1% to $65.19
- Closed at $65.19, +3.05% vs the prior close of $63.26. Day range $62.85β$65.30, opened at $62.94.
- Volume was 220.40K shares, 0.9x its 50-day average of 250.54K.
- Price is -2.6% vs its 50-day average ($66.96) and -13.2% vs its 200-day average ($75.14).
- 52-week range $54.48β$92.08; today's close sits at 28% of that range, 29.2% below the 52-week high.
Oct 12, 2026 β DBD dips 0.6% to $63.26
- Closed at $63.26, -0.64% vs the prior close of $63.67. Day range $63.12β$64.24, opened at $63.39.
- Volume was 173.20K shares, 0.7x its 50-day average of 256.83K.
- Price is -5.9% vs its 50-day average ($67.21) and -15.8% vs its 200-day average ($75.16).
- 52-week range $54.48β$92.08; today's close sits at 23% of that range, 31.3% below the 52-week high.
Oct 9, 2026 β DBD rises 1.0% to $63.67
- Closed at $63.67, +1.03% vs the prior close of $63.02. Day range $62.58β$63.68, opened at $62.80.
- Volume was 220.00K shares, 0.8x its 50-day average of 261.00K.
- Price is -5.6% vs its 50-day average ($67.42) and -15.3% vs its 200-day average ($75.18).
- 52-week range $54.48β$92.08; today's close sits at 24% of that range, 30.9% below the 52-week high.
Oct 8, 2026 β DBD slides 3.1% to $63.02, 3 down days in a row
- Closed at $63.02, -3.11% vs the prior close of $65.04. Day range $62.59β$65.05, opened at $64.78.
- Volume was 242.50K shares, 0.9x its 50-day average of 269.15K.
- Price is -6.7% vs its 50-day average ($67.57) and -16.2% vs its 200-day average ($75.20).
- 52-week range $54.48β$92.08; today's close sits at 23% of that range, 31.6% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 β DBD dips 0.7% to $65.04
- Closed at $65.04, -0.67% vs the prior close of $65.48. Day range $64.24β$65.46, opened at $65.28.
- Volume was 172.90K shares, 0.6x its 50-day average of 273.16K.
- Price is -4.1% vs its 50-day average ($67.81) and -13.5% vs its 200-day average ($75.23).
- 52-week range $54.48β$92.08; today's close sits at 28% of that range, 29.4% below the 52-week high.
Oct 6, 2026 β DBD ends flat (-0.2%) to $65.48
- Closed at $65.48, -0.23% vs the prior close of $65.63. Day range $65.35β$67.18, opened at $66.42.
- Volume was 171.30K shares, 0.6x its 50-day average of 276.85K.
- Price is -4.2% vs its 50-day average ($68.32) and -13.0% vs its 200-day average ($75.24).
- 52-week range $54.48β$92.08; today's close sits at 29% of that range, 28.9% below the 52-week high.
Oct 5, 2026 β DBD rises 2.9% to $65.63, 4 up days in a row
- Closed at $65.63, +2.92% vs the prior close of $63.77. Day range $63.77β$67.28, opened at $63.77.
- Volume was 392.70K shares, 1.4x its 50-day average of 274.39K.
- Price is -4.6% vs its 50-day average ($68.83) and -12.8% vs its 200-day average ($75.25).
- 52-week range $54.48β$92.08; today's close sits at 30% of that range, 28.7% below the 52-week high.
- That makes 4 straight gains.
Oct 2, 2026 β DBD rises 0.9% to $63.77, 3 up days in a row
- Closed at $63.77, +0.93% vs the prior close of $63.18. Day range $63.06β$65.52, opened at $64.59.
- Volume was 277.40K shares, 1.0x its 50-day average of 273.88K.
- Price is -8.0% vs its 50-day average ($69.30) and -15.3% vs its 200-day average ($75.26).
- 52-week range $54.48β$92.08; today's close sits at 25% of that range, 30.7% below the 52-week high.
- That makes 3 straight gains.
DBD latest news & SEC filings
Every SEC filing by or about DBD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Jul 31, 2026 Β· Form SCHEDULE 13D/A β Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 31, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Timko Thomas S bought 700 shares at $72.29 (β$50.60K) on Jul 31, 2026
- Timko Thomas S bought 700 shares at $72.29 (β$50.60K) on Jul 31, 2026
- Timko Thomas S bought 700 shares at $72.29 (β$50.60K) on Jul 31, 2026
- Timko Thomas S bought 700 shares at $72.29 (β$50.60K) on Jul 31, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 29, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $930.80M (prior year $915.20M) (+1.7% vs Jun 30, 2025)
- Net income: $15.50M (prior year $12.20M) (+27.0% vs Jun 30, 2025)
- Diluted EPS: $0.44 (prior year $0.33) (+33.3% vs Jun 30, 2025)
Jul 29, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 30, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Connolly Brian D sold 100,000 shares at $84.80 (β$8.48M) on Jun 26, 2026
- Connolly Brian D sold 100,000 shares at $84.80 (β$8.48M) on Jun 26, 2026
- Millstreet Capital Management Llc sold 100,000 shares at $84.80 (β$8.48M) on Jun 26, 2026
- Millstreet Capital Management Llc sold 100,000 shares at $84.80 (β$8.48M) on Jun 26, 2026
- Kelleher Craig sold 100,000 shares at $84.80 (β$8.48M) on Jun 26, 2026
- Kelleher Craig sold 100,000 shares at $84.80 (β$8.48M) on Jun 26, 2026
- β¦plus 6 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 26, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Connolly Brian D sold 2,741 shares at $85.06 (β$233.15K) on Jun 25, 2026
- Connolly Brian D sold 2,741 shares at $85.06 (β$233.15K) on Jun 25, 2026
- Millstreet Capital Management Llc sold 2,741 shares at $85.06 (β$233.15K) on Jun 25, 2026
- Millstreet Capital Management Llc sold 2,741 shares at $85.06 (β$233.15K) on Jun 25, 2026
- Kelleher Craig sold 2,741 shares at $85.06 (β$233.15K) on Jun 25, 2026
- Kelleher Craig sold 2,741 shares at $85.06 (β$233.15K) on Jun 25, 2026
- β¦plus 3 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 26, 2026 Β· Form SCHEDULE 13D/A β Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade DBD
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 12, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Oct 28, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.60% (largest 3.5%).
- Liquidity: about 227.35K shares (β$15.19M) trade per day on average.
- 52-week position: $66.83 vs a range of $54.48β$92.08 (33% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 21 sales; latest: Thomas S Timko bought 700 shares on Jul 31, 2026.
- Latest filings: 10-Q Jul 29, 2026; 8-K Jul 29, 2026; 8-K May 26, 2026.
- Share count: 33.95M shares outstanding (Jul 21, 2026), -7.3% vs a year earlier β the company has been reducing its share count.
- Listing: NYSE Β· industry: Calculating & Accounting Machines (No Electronic Computers).
DBD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 66.70 | 67.56 | 65.92 | 66.83 | 211.34K |
| Oct 15, 2026 | 64.16 | 66.88 | 63.77 | 66.57 | 188.70K |
| Oct 14, 2026 | 64.21 | 64.80 | 63.67 | 64.29 | 188.30K |
| Oct 13, 2026 | 62.94 | 65.30 | 62.85 | 65.19 | 220.40K |
| Oct 12, 2026 | 63.39 | 64.24 | 63.12 | 63.26 | 173.20K |
| Oct 9, 2026 | 62.80 | 63.68 | 62.58 | 63.67 | 220.00K |
| Oct 8, 2026 | 64.78 | 65.05 | 62.59 | 63.02 | 242.50K |
| Oct 7, 2026 | 65.28 | 65.46 | 64.24 | 65.04 | 172.90K |
| Oct 6, 2026 | 66.42 | 67.18 | 65.35 | 65.48 | 171.30K |
| Oct 5, 2026 | 63.77 | 67.28 | 63.77 | 65.63 | 392.70K |
| Oct 2, 2026 | 64.59 | 65.52 | 63.06 | 63.77 | 277.40K |
| Oct 1, 2026 | 61.53 | 63.51 | 61.01 | 63.18 | 333.30K |
| Sep 30, 2026 | 60.37 | 61.35 | 59.28 | 61.22 | 337.40K |
| Sep 29, 2026 | 61.11 | 61.85 | 59.88 | 60.25 | 238.10K |
| Sep 28, 2026 | 61.91 | 62.73 | 60.87 | 60.89 | 261.20K |
| Sep 25, 2026 | 63.01 | 63.33 | 62.31 | 62.72 | 122.40K |
| Sep 24, 2026 | 62.85 | 63.42 | 62.34 | 62.47 | 173.60K |
| Sep 23, 2026 | 64.00 | 64.46 | 63.02 | 63.04 | 171.90K |
| Sep 22, 2026 | 64.32 | 64.97 | 63.98 | 64.39 | 226.20K |
| Sep 21, 2026 | 64.15 | 65.00 | 62.38 | 63.37 | 224.20K |
About Diebold Nixdorf
Diebold Nixdorf (DBD) is listed on the NYSE and classified by the SEC under βCalculating & Accounting Machines (No Electronic Computers)β. Its business address is in NORTH CANTON, OH. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 28823.
DBD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Maura A. Markus | Director | May 22, 2026 |
| Octavio Marquez | President and CEO | May 27, 2026 |
| Colin J. Parris | Director | May 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Frank Tobias Baur | EVP, Chief Operating Officer | Mar 3, 2026 |
| Octavio Marquez | President and CEO | May 27, 2026 |
| Jonathan Myers | EVP, Chief Revenue Officer | May 22, 2026 |
| Elizabeth Christine Radigan | EVP, Chief Administrative Ofcr | Mar 3, 2026 |
| Jeffrey M Sesplankis | SVP, Chief Accounting Officer | Mar 9, 2026 |
| Rajesh K Singh | EVP, Chief Information Officer | May 13, 2026 |
| Thomas S Timko | EVP, CFO | Jul 31, 2026 |
| Andrew Joseph Zosel | EVP, Chief Prod & Tech Officer | Mar 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 31, 2026 | Thomas S Timko | Buy | 700 | $72.29 |
| Jul 31, 2026 | Thomas S Timko | Buy | 700 | $72.29 |
| Jul 31, 2026 | Thomas S Timko | Buy | 700 | $72.29 |
| Jul 31, 2026 | Thomas S Timko | Buy | 700 | $72.29 |
| Jun 26, 2026 | Brian D Connolly | Sale | 100,000 | $84.80 |
| Jun 26, 2026 | Brian D Connolly | Sale | 100,000 | $84.80 |
| Jun 26, 2026 | Capital Management Llc Millstreet | Sale | 100,000 | $84.80 |
| Jun 26, 2026 | Capital Management Llc Millstreet | Sale | 100,000 | $84.80 |
| Jun 26, 2026 | Craig Kelleher | Sale | 100,000 | $84.80 |
| Jun 26, 2026 | Craig Kelleher | Sale | 100,000 | $84.80 |
| Jun 26, 2026 | Brian D Connolly | Sale | 100,000 | $84.80 |
| Jun 26, 2026 | Brian D Connolly | Sale | 100,000 | $84.80 |
| Jun 26, 2026 | Capital Management Llc Millstreet | Sale | 100,000 | $84.80 |
| Jun 26, 2026 | Capital Management Llc Millstreet | Sale | 100,000 | $84.80 |
| Jun 26, 2026 | Craig Kelleher | Sale | 100,000 | $84.80 |
DBD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $3.81B | $94.60M | 2.54 | $300.70M |
| Dec 31, 2024 | $3.75B | $-16.50M | -0.44 | $149.20M |
| Dec 31, 2022 | $3.46B | $-581.40M | -7.36 | $-387.90M |
| Dec 31, 2021 | $3.91B | $-78.80M | -1.01 | $123.30M |
| Dec 31, 2020 | $3.90B | $-269.10M | -3.47 | $18.00M |
Latest balance sheet: total assets $3.74B, total liabilities $2.76B, cash $358.60M (as of Jun 30, 2026).
DBD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $75.17 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $76.81 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $75.59 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $63.24 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $59.47 |
| May 7, 2025 | 8-K Item 2.02 (results) | $44.00 |
| Feb 12, 2025 | 8-K Item 2.02 (results) | $46.36 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $43.04 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | β |
| May 2, 2024 | 8-K Item 2.02 (results) | β |
| Feb 14, 2024 | 8-K Item 2.02 (results) | β |
| Nov 9, 2023 | 8-K Item 2.02 (results) | β |
Related stocks Β· Calculating & Accounting Machines (No Electronic Computers)
NCR Atleos (NATL)NCR Voyix (VYX)Par Technology (PAR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on DBD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.